Related references
Note: Only part of the references are listed.Antiviral therapy of hepatitis C in 2014: Do we need resistance testing?
Maximilian David Schneider et al.
ANTIVIRAL RESEARCH (2014)
Analysis of hepatitis C viral kinetics during administration of two nucleotide analogues: sofosbuvir (GS-7977) and GS-0938
Jeremie Guedj et al.
ANTIVIRAL THERAPY (2014)
Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life
Jeremie Guedj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Analysis of Hepatitis C Virus Decline during Treatment with the Protease Inhibitor Danoprevir Using a Multiscale Model
Libin Rong et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Hepatitis C viral kinetics with the nucleoside polymerase inhibitor mericitabine (RG7128)
Jeremie Guedj et al.
HEPATOLOGY (2012)
Understanding silibinin's modes of action against HCV using viral kinetic modeling
Jeremie Guedj et al.
JOURNAL OF HEPATOLOGY (2012)
Twice-weekly pegylated interferon-α-2a and ribavirin results in superior viral kinetics in HIV/hepatitis C virus co-infected patients compared to standard therapy
Alison A. Murphy et al.
AIDS (2011)
Silibin's Mode of Action Against Hepatitis C Virus: A Controversy Yet to Be Resolved
Harel Dahari et al.
HEPATOLOGY (2011)
Second-Phase Hepatitis C Virus RNA Decline During Telaprevir-Based Therapy Increases With Drug Effectiveness: Implications for Treatment Duration
Jeremie Guedj et al.
HEPATOLOGY (2011)
A Comprehensive Hepatitis C Viral Kinetic Model Explaining Cure
E. Snoeck et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Pharmacodynamics of PEG-IFN-α-2a in HIV/HCV co-infected patients: Implications for treatment outcomes
Harel Dahari et al.
JOURNAL OF HEPATOLOGY (2010)
Understanding hepatitis C viral dynamics with direct-acting antiviral agents due to the interplay between intracellular replication and cellular infection dynamics
J. Guedj et al.
JOURNAL OF THEORETICAL BIOLOGY (2010)
Rapid Emergence of Protease Inhibitor Resistance in Hepatitis C Virus
Libin Rong et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Modeling HCV kinetics under therapy using PK and PD information
Emi Shudo et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Modeling Complex Decay Profiles of Hepatitis B Virus During Antiviral Therapy
Harel Dahari et al.
HEPATOLOGY (2009)
The Magnus expansion and some of its applications
S. Blanes et al.
PHYSICS REPORTS-REVIEW SECTION OF PHYSICS LETTERS (2009)
Modeling amantadine treatment of influenza A virus in vitro
Catherine A. A. Beauchemin et al.
JOURNAL OF THEORETICAL BIOLOGY (2008)
Modelling the kinetics of hepatitis C virus RNA decline over 4 weeks of treatment with pegylated interferon α-2b
E. Shudo et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Modelling hepatitis C virus kinetics during treatment with pegylated interferon α-2b:: errors in the estimation of viral kinetic parameters
E. Shudo et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor β-D-2′-Deoxy-2′-fluoro-2′-C-methylcytidine (PSI-6130) and identification of a novel active 5′-triphosphate species
Han Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Kinetics of influenza A virus infection in humans
Prasith Baccam et al.
JOURNAL OF VIROLOGY (2006)
Pharmacodynamics of PEG-IFN α differentiate HIV/HCV coinfected sustained virological responders from nonresponders
AH Talal et al.
HEPATOLOGY (2006)
Complex patterns of viral load decay under antiretroviral therapy: influence of pharmacokinetics and intracellular delay
NM Dixit et al.
JOURNAL OF THEORETICAL BIOLOGY (2004)
Primer unblocking by HIV-1 reverse transcriptase and resistance to nucleoside RT inhibitors (NRTIs)
V Goldschmidt et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2004)
Modelling how ribavirin improves interferon response rates in hepatitis C virus infection
NM Dixit et al.
NATURE (2004)
Modelling viral and immune system dynamics
AS Perelson
NATURE REVIEWS IMMUNOLOGY (2002)
Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed
SR Lewin et al.
HEPATOLOGY (2001)
Share Paper
